Alyeska Investment Group
PRVA icon

Alyeska Investment Group’s Privia Health PRVA Stock Holding History

Alyeska Investment Group’s Portfolio PRVA Stock Details PRVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-300,000
Closed -$5.87M – 633
2024
Q4 		$5.87M Buy
300,000
+50,000
+20% +$991K 0.02% 390
2024
Q3 		$4.55M Buy
+250,000
New +$4.77M 0.02% 365
2023
Q3 		– Sell
-812,312
Closed -$21.2M – 602
2023
Q2 		$21.2M Buy
812,312
+748,439
+1,172% +$19.8M 0.16% 180
2023
Q1 		$1.76M Sell
63,873
-837,752
-93% -$22.1M 0.02% 360
2022
Q4 		$20.5M Buy
901,625
+780,086
+642% +$21.7M 0.21% 146
2022
Q3 		$4.14M Sell
121,539
-230,606
-65% -$8.53M 0.05% 275
2022
Q2 		$10.3M Buy
+352,145
New +$8.95M 0.12% 206
2022
Q1 		– Sell
-200,000
Closed -$5.17M – 653
2021
Q4 		$5.17M Buy
+200,000
New +$4.99M 0.06% 272

Other funds holding PRVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Alyeska Investment Group's PRVA Position: Q1 2025 in Review

Alyeska Investment Group sold out of Privia Health (PRVA) in Q1 2025, closing a stake of 300,000 shares — an estimated $5.87M sold.

Alyeska Investment Group first reported a position in PRVA in Q4 2021 and held it in 8 quarters. The position peaked at $21.2M in Q2 2023. 248 funds tracked by Wall St. Rank hold PRVA as of Q1 2025.

  • Alyeska Investment Group reported no remaining Privia Health position as of Q1 2025 after selling out during the quarter.
  • Alyeska Investment Group sold 300,000 Privia Health shares in Q1 2025, an estimated $5.87M.
  • Alyeska Investment Group first reported a position in Privia Health in Q4 2021 and held it in 8 quarters.
  • Alyeska Investment Group's Privia Health position peaked at $21.2M in Q2 2023.
  • 248 funds tracked by Wall St. Rank held Privia Health as of Q1 2025.

Based on Alyeska Investment Group's 13F filing for Q1 2025, filed 15 May 2025.